CCCC
Price
$3.77
Change
-$0.28 (-6.91%)
Updated
Dec 18, 04:09 PM (EDT)
64 days until earnings call
VRTX
Price
$450.05
Change
-$19.19 (-4.09%)
Updated
Dec 18, 04:35 PM (EDT)
55 days until earnings call
Ad is loading...

CCCC vs VRTX

Header iconCCCC vs VRTX Comparison
Open Charts CCCC vs VRTXBanner chart's image
C4 Therapeutics
Price$3.77
Change-$0.28 (-6.91%)
Volume$3.01K
CapitalizationN/A
Vertex Pharmaceuticals
Price$450.05
Change-$19.19 (-4.09%)
Volume$1.3K
CapitalizationN/A
CCCC vs VRTX Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. VRTX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and VRTX is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (CCCC: $4.05 vs. VRTX: $469.24)
Brand notoriety: CCCC and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 85% vs. VRTX: 97%
Market capitalization -- CCCC: $304.24M vs. VRTX: $120.84B
CCCC [@Biotechnology] is valued at $304.24M. VRTX’s [@Biotechnology] market capitalization is $120.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • VRTX’s FA Score: 1 green, 4 red.
According to our system of comparison, VRTX is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while VRTX’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 4 bearish.
  • VRTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CCCC and VRTX are a good buy in the short-term.

Price Growth

CCCC (@Biotechnology) experienced а -6.03% price change this week, while VRTX (@Biotechnology) price change was +0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.43%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

CCCC is expected to report earnings on Feb 20, 2025.

VRTX is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($121B) has a higher market cap than CCCC($304M). VRTX YTD gains are higher at: 15.324 vs. CCCC (-28.319). VRTX has higher annual earnings (EBITDA): 518M vs. CCCC (-103.45M). VRTX has more cash in the bank: 6.52B vs. CCCC (256M). CCCC has less debt than VRTX: CCCC (67.1M) vs VRTX (1.7B). VRTX has higher revenues than CCCC: VRTX (10.6B) vs CCCC (33.7M).
CCCCVRTXCCCC / VRTX
Capitalization304M121B0%
EBITDA-103.45M518M-20%
Gain YTD-28.31915.324-185%
P/E RatioN/A32.76-
Revenue33.7M10.6B0%
Total Cash256M6.52B4%
Total Debt67.1M1.7B4%
FUNDAMENTALS RATINGS
VRTX: Fundamental Ratings
VRTX
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
13
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
37
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCVRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 7 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
55%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 6 days ago
43%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
59%
View a ticker or compare two or three
Ad is loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS7.69-0.08
-1.03%
iTeos Therapeutics
IT497.42-5.16
-1.03%
Gartner
VMI326.32-5.15
-1.55%
Valmont Industries
MEG17.51-0.56
-3.10%
Montrose Environmental Group
RFIL3.75-0.16
-4.09%
RF Industries Ltd

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-6.03%
KYMR - CCCC
50%
Loosely correlated
-1.76%
CRSP - CCCC
49%
Loosely correlated
+0.88%
BEAM - CCCC
47%
Loosely correlated
-1.21%
ADCT - CCCC
47%
Loosely correlated
+6.50%
ACAD - CCCC
46%
Loosely correlated
+0.40%
More

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with CCCC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
+0.25%
CCCC - VRTX
39%
Loosely correlated
-6.03%
STTK - VRTX
37%
Loosely correlated
+5.50%
TECH - VRTX
37%
Loosely correlated
-1.17%
GMAB - VRTX
35%
Loosely correlated
+0.05%
REGN - VRTX
34%
Loosely correlated
+2.09%
More